Skip to main content

Effects of continuous hypoxia on flow-mediated dilation in the cerebral and systemic circulation: on the regulatory significance of shear rate phenotype

Abstract

Emergent evidence suggests that cyclic intermittent hypoxia increases cerebral arterial shear rate and endothelial function, whereas continuous exposure decreases anterior cerebral oxygen (O2) delivery. To examine to what extent continuous hypoxia impacts cerebral shear rate, cerebral endothelial function, and consequent cerebral O2 delivery (CDO2), eight healthy males were randomly assigned single-blind to 7 h passive exposure to both normoxia (21% O2) and hypoxia (12% O2). Blood flow in the brachial and internal carotid arteries were determined using Duplex ultrasound and included the combined assessment of systemic and cerebral endothelium-dependent flow-mediated dilatation. Systemic (brachial artery) flow-mediated dilatation was consistently lower during hypoxia (P = 0.013 vs. normoxia), whereas cerebral flow-mediated dilation remained preserved (P = 0.927 vs. normoxia) despite a reduction in internal carotid artery antegrade shear rate (P = 0.002 vs. normoxia) and CDO2 (P < 0.001 vs. normoxia). Collectively, these findings indicate that the reduction in CDO2 appears to be independent of cerebral endothelial function and contrasts with that observed during cyclic intermittent hypoxia, highlighting the regulatory importance of (hypoxia) dose duration and flow/shear rate phenotype.

Introduction

In peripheral conduit arteries, it is well established that an increase in antegrade shear rate (SR) stimulated by an acute elevation in blood flow improves systemic vascular endothelium-dependent vasodilatory function [1,2,3]. This provides the hemodynamic basis underlying the vascular protective benefits of physical exercise to improve systemic endothelial function (EF) and decrease the risk of cardiovascular disease [4]. Equally, cerebrovascular endothelial dysfunction predisposes to stroke and neurodegenerative diseases [5, 6] and can be countered by flow-mediated elevations in SR [6].

Recently, cyclic intermittent hypoxia, consisting of 3–10 bouts of intermittent exposures (3–6 min) to moderate hypoxia (10–15% O2), was shown to improve cerebral EF subsequent to cerebral blood flow (CBF)-mediated sinusoidal elevations in cerebral SR, implying that intermittent hypoxia may be a useful non-pharmacological adjunct to optimize cerebrovascular health [7]. In further support, cyclic intermittent exercise increases cerebral SR more effectively than continuous steady-state exercise [8]. Therefore, the improvement of EF may be dictated or subject to regulation by the specific flow/SR ‘phenotype’. Given that continuous exposure to hypoxia is also useful as a clinical therapy [9, 10], further mechanistic investigation is required. To what extent, if indeed any, continuous steady-state exposure to hypoxia, a stimulus defined by an entirely different hemodynamic phenotype (i.e., non-cyclic/sinusoidal), impacts cerebral SR and consequent EF.

Our recent study [11] demonstrated that CDO2 decreased in the anterior cerebral circulation during continuous exposure (7 h) to hypoxia, indicating that steady-state exposure, unlike its cyclic intermittent counterpart, attenuates cerebral bioenergetic function. The physiological mechanisms underlying these divergent findings remain to be examined. Furthermore, there are no integrated studies to the best of our knowledge that have simultaneously examined changes in both local (cerebral) and systemic (brachial) EF during continuous hypoxia. This is surprising, given the controversial findings relating to systemic flow-mediated dilation (FMD) in hypoxia [12,13,14,15,16,17,18,19,20,21,22] combined with the observation that retrograde flow is confined to the systemic and not the cerebral arterial circulation [11, 23, 24]. Specifically, the increase in retrograde flow [22, 25, 26], known to attenuate systemic EF [27], given its absence in the cerebral circulation [8, 23, 24, 28] would result in preserved (i.e., maintained) EF.

In light of these knowledge gaps, we conducted a randomized, cross-over, single-blind trial in normoxia and hypoxia to examine to what extent continuous steady-state exposure to inspiratory hypoxia affects the integrated CBF-mediated regulation of cerebral and systemic SR and consequent EF. We hypothesized that unlike cyclic intermittent exposure, continuous steady-state exposure to hypoxia would not alter cerebral SR or EF, and that the cerebral FMD response to continuous hypoxia would differ from that observed in the systemic circulation.

Materials and methods

Participants

Eight physically active males (age: 23 ± 2 y, stature: 1.81 ± 0.04 m, mass: 80 ± 7 kg) were recruited from the local University student population by word-of-mouth, social media platforms and advertisements. All participants lived close to sea level (90 m) and had not been exposed to simulated or terrestrial high-altitude in the previous 12 months. Following a medical examination, they were confirmed to be healthy and free of any known diseases. Furthermore, they were not taking any prescribed or over-the-counter medications or supplements. They were instructed to refrain from physical activity, caffeine, and alcohol and to follow a low nitrate/nitrite diet 24 h prior to formal experimentation [29].

Design

The present study adopted a randomized, cross-over, single-blind design with select measurements (see below) performed throughout (Fig. 1). Participants completed two different experimental trials in a normobaric environmental chamber (~ 120 m3) maintained at 21 °C and 50% relative humidity (Design Environmental, Ebbw Vale, UK). They were randomly assigned single-blind to complete 7 h passive exposure to normoxia (FiO2 = 0.21) and 7 h of normobaric hypoxia (FiO2 = 0.12), separated by 7 days. Participants arrived at the laboratory (between 8:00 and 9:00 A.M.) following a 12 h overnight fast and consumed a standardized meal (30 g of oats with 180 mL water), 30 min before the experimental trials. They received the standardized meal again at 2 h, 4 h, and 6 h to maximize compliance and avoid hunger/dehydration [30]. Flow-mediated dilation (FMD), as an index of systemic vascular EF, of the BA (systemic FMD) and FMD, as an index of cerebral EF, of the internal carotid artery (ICA, cerebral FMD) were determined every 2 h from the first (systemic FMD, 4 repeat measurements) or second hour (cerebral FMD, 3 repeat measurements) of experimentation (Fig. 1).

Fig. 1
figure 1

Experimental protocol

Measurements

Cardiopulmonary function

Heart rate (HR) was monitored by ECG (lead II) and beat-to-beat arterial blood pressure (ABP) was monitored continuously via finger photoplethysmography (Finometer PRO, Finapres Medical Systems, Amsterdam, The Netherlands). SpO2 was quantified via finger-pulse oximetry (WristOx2® 3150, Nonin, Minnesota, USA). The finometer blood pressure waveform was used to calculate mean arterial blood pressure (MAP) after calibrating values to the average of two automated brachial blood pressure measurements (Life Source, A&D Medical, model: UA767FAM), taken over a 5-min resting baseline period. The end-tidal partial pressure of carbon dioxide (PETCO2) was measured via a mouthpiece and an automatic breath-by-breath respiratory gas-analyzing system consisting of a differential pressure transducer, sampling tube, filter, suction pump, and mass spectrometer (ML 206, ADInstruments, UK). All data were recorded continuously at 1 kHz.

Hemodynamic function

Diameter and blood velocity in the BA and ICA were determined using Duplex ultrasound (BA, Terason t3000, ICA; Vivid-i, GE Medical Systems, Tokyo, Japan). BA measurements were performed in the longitudinal section ~ 3–5 cm above the antecubital fossa. ICA measurements were performed ~ 1.0–1.5 cm distal to the carotid bifurcation with the participant’s chin slightly elevated. The steering angle was fixed to 60° and the sample volume was placed in the center of the vessel adjusted to cover the entire vascular lumen. We captured arterial images and associated velocity waveforms at 30 Hz and stored them in a computer for the subsequent assessment of systemic and cerebral FMD (see below).

Systemic FMD

BA FMD (as systemic FMD) was determined as the percent change in peak BA diameter during ischemia-induced reactive hyperemia from (pre-ischemic) resting control baseline according to established methods [31]. We used an inflation/deflation pneumatic cuff to provide the ischemic stimulus. Specifically, we recorded baseline scans assessing resting vessel diameter and velocity over 1 min. We then inflated the cuff to > 220 mmHg for 5 min. We resumed diameter and blood velocity recordings 30 s before cuff deflation and continued recording for 3 min thereafter.

Cerebral FMD

ICA FMD (as cerebral FMD) was determined as the percent change in peak ICA diameter during hypercapnia-induced reactive hyperemia [7, 32, 33]. We recorded a 1 min baseline period followed by 3 min of breathing 5% CO2 in 21% O2 (normoxic trial) or 12% O2 (hypoxic trial) with balanced nitrogen (N2) balance from a 200L Douglas Bag via Falconia tubing (Cranleigh, UK) connected to the inspiratory port of a two-way nonrebreathing valve (Hans Rudolph, 2400 series).

Data analysis

HR, ABP and PETCO2 were continuously measured throughout and averaged over 30 s every 2 h and complemented by the assessment of cerebral FMD. BA and ICA SR and FMD were analyzed during the hyperemic challenge (see above).

For systemic FMD, BA diameter and mean blood velocity during the FMD test were assessed at 30 Hz using custom-designed edge-detection and wall-tracking software (Blood Flow Analysis, Version 5.1). BA parameters were derived using an algorithm reported previously [34, 35]. One minute of baseline data were analysed to yield median baseline diameter (Dbase), peak (Dpeak), and time-to-peak diameter, blood flow and SR characteristics [34, 36].

In the cerebral FMD, similarly with systemic FMD, ICA diameter and blood velocity were analyzed at 30 Hz using custom-designed edge-detection and wall-tracking software (version 2.0.1, S-13037, Takei Kiki Kogyo, Tokyo, Japan). We interpolated ICA parameters to 1 Hz prior to subjecting data to a two-stage filtering process (median filter and Savitzky–Golay finite impulse response smoothing filter). In brief, (Dbase) and SR were analysed during the last minute and peak diameter (Dpeak) were then assessed visually to ensure that: the detected peak SR preceded the detected Dpeak [7, 31,32,33,34]. BA and ICA SR were calculated using the equation; 4 × mean velocity/arterial diameter. In addition, the SR area under the curve (SRAUC) was calculated for data up to the point of Dpeak using the trapezoid rule [3, 36]. FMD was calculated using peak and baseline values [(Dpeak–Dbase)/Dbase × 100]. Normalized FMD was calculated by dividing FMD by the SRAUC.

Cerebral oxygen delivery (CDO2) were determined as CDO2 (mL/min)  = ICA blood flow × (estimated) arterial O2 content (CaO2), calculated as \(\left(\mathrm{Hb }(\mathrm{g}/\mathrm{dL})\times 1.39 \times \frac{{\mathrm{SaO}}_{2 \text{(\%)} }}{100}\right)\) excluding (albeit minor) contributions from dissolved O2 (0.003 × arterial PO2), since we did not perform arterial catheterization.

Statistical analysis

Power calculation

Data were analyzed using G Power 3.1 software. Assuming a comparable hypoxia-induced reduction (14%) and corresponding effect size (η2 = 1.267) for brachial (systemic) FMD previously observed by our group in a similar demographic [15], the present study required a (minimum) sample size of 6 participants (within groups, repeated measures) to achieve a (minimum) power of 0.80 at p < 0.05. We chose to further inflate this to n = 8 during recruitment given the potential for loss to follow-up owing to technical failure/drop-out. We were not in a position to prospectively power against cerebral FMD given that this was the first study to investigate this metric.

Inferential statistics

All data were analyzed using SPSS (IBM SPSS Statistics Version 28.0) and expressed as mean ± standard deviation (SD). A linear mixed model with fixed effects for Trial (normoxia vs. hypoxia) or Inspirate (eucapnia vs. hypercapnia) and Time (0–7 h) was used to compare acquired data. In addition, the change in hypercapnia on cardiopulmonary data from eupnea to hypercapnia during cerebral FMD assessment (i.e., ΔHR, MAP and PETCO2) were evaluated using a linear mixed model. To identify the effect of Dbase, corrected systemic and cerebral FMD were calculated by using Dbase as covariates [37, 38]. Differences between means were located using Bonferroni-corrected paired samples t tests. Pearson correlation was used to analyze the statistical relationship between CDO2 and cerebral FMD. Significance was determined at an alpha level of 0.05 for all two-tailed tests.

Results

Loss to follow-up

Systemic FMD was determined in all participants, whereas ICA velocity and/or diameter data were lost in 2 or 3 participants during hypercapnia. Thus, the cerebral FMD sample size reflects data obtained in 6 participants except for 4 h normoxia and 6 h hypoxia (n = 5, Fig. 3).

Cardiopulmonary function

MAP and PETCO2 were lower in hypoxia (P < 0.001 vs. normoxia), whereas HR was higher (P = 0.001 vs. normoxia). The hypercapnia stimulation during cerebral FMD assessment did not affect cardiovascular variables (HR, MAP, and PETCO2, Table 1).

Table 1 Cardiopulmonary responses

Blood flow

BA blood flow did not change during hypoxia (P = 0.359 vs. normoxia, Fig. 2A). ICA blood flow was higher at 2nd h during hypoxia than that of the normoxia condition (P = 0.001), while ICA blood flow did not differ between both conditions from 4th h to the end of the hypoxia exposure.

Fig. 2
figure 2

A Blood flow in brachial artery (BA) and internal carotid artery (ICA), and B antegrade shear rate (SR), retrograde SR in BA and antegrade SR in ICA (B) during hypoxia and normoxia. n = 8. Values are mean ± SD. *P < 0.05 different vs. normoxia, P < 0.05 different vs. 2 h

Hypoxia did not alter BA antegrade SR (P = 0.336 vs. normoxia, Fig. 2B), whereas BA retrograde SR (absolute values) was consistently higher throughout (P < 0.001 vs. normoxia). In contrast, retrograde SR was not observed in the ICA, whereas ICA antegrade SR during hypoxia was lower than that of normoxia (P = 0.002 vs. normoxia).

Systemic FMD

Hypoxia did not alter BA Dbase, Dpeak or SRAUC (P > 0.05 vs. normoxia; Table 2). Systemic FMD and normalized systemic FMD were consistently lower (P = 0.013 and P = 0.004 vs. normoxia, Fig. 3A). In addition, corrected systemic FMD remained lower during hypoxia (P = 0.053).

Table 2 Systemic flow-mediated dilation
Fig. 3
figure 3

A Systemic (brachial artery, BA; n = 8) and B cerebral (internal carotid artery, ICA; n = 5 or 6) flow-mediated dilation (FMD) and normalized FMD during hypoxia and normoxia. Cerebral FMD sample size at each timepoint are in brackets along the horizontal axis. Values are mean ± SD

Cerebral FMD

Both ICA Dbase and Dpeak were slightly higher during hypoxia (P < 0.001 vs. normoxia), whereas in contrast, ICA SRAUC, cerebral FMD and normalized cerebral FMD were not altered (P = 0.927 and P = 0.228 vs. normoxia, Fig. 3B). In addition, corrected cerebral FMD remained unaltered during hypoxia (P = 0.480). While CDO2 was lower during hypoxia (P < 0.001 vs. normoxia), we failed to observe a relationship between CDO2 and cerebral FMD (r = 0.097, P = 0.586, Fig. 4).

Fig. 4
figure 4

A Cerebral oxygen delivery (CDO2) and B relationship between CDO2 and cerebral FMD

Discussion

Extending prior research highlighting the cerebrovascular benefits associated with cyclic intermittent hypoxia, the present study examined to what extent continuous steady-state exposure impacts the integrated SR and FMD responses in the systemic and cerebral circulation. Our primary finding is that while continuous hypoxia was associated with a reduction in systemic FMD, it failed to impact cerebral FMD despite a reduction in ICA antegrade SR. These findings contrast with those observed during cyclic intermittent hypoxia [7], highlighting the regulatory importance of (hypoxia) dose duration and flow/SR phenotype. Furthermore, the reduction in anterior CDO2 appears to be independent of local changes in EF.

Systemic FMD

In the present study, systemic FMD was attenuated in hypoxia, whereas cerebral FMD remained preserved. The systemic FMD response to hypoxia remains controversial with some studies demonstrating a reduction [12,13,14,15,16,17,18], whereas others have failed to document any change [19,20,21,22]. These inconsistent findings may be related to differences in the duration and severity of hypoxia [16] and protocol including the hyperemic stimulus [12, 14, 15, 19, 21]. A recent study [16] reported that systemic FMD was reduced during 30 min of mild (SaO2 93%) and moderate (SaO2 83%) hypoxia. The reduction in systemic FMD was partly attributable to the observed (25%) reduction in SRAUC. In further support, Tremblay et al. [17] identified a 29% reduction in systemic FMD during acute hypoxia (20 min) and 25% reduction during sustained hypoxia (5–7 days) that correlated with changes in baseline BA mean and antegrade SR. However, these findings contrast with the present study given that hypoxia failed to alter BA antegrade SR, whereas the increase in BA retrograde SR was more marked and sustained. Therefore, our findings suggest that it is the increase in BA retrograde (P < 0.001, Fig. 2B) and not antegrade SR that underlies the hypoxia-induced reduction in systemic FMD (P = 0.239).

Interestingly, a reduction in systemic FMD during imposed oscillatory shear stress was found to be present even in normoxia, indicating that the shear stress phenotype may contribute to impaired vascular EF [17]. Indeed, the endothelium appears to be more susceptible to oscillatory shear stress during hypoxia, as the oscillatory shear stress intervention elicited an impairment in FMD during hypoxia but not normoxia combined with the observed dissociation between the change in SRAUC and FMD [21]. Moreover, acute and progressive increases in baseline BA retrograde SR have been shown to elicit a dose-dependent impairment in systemic FMD [27]. Collectively, it is conceivable that alterations in the SR phenotype rather than hypoxia per se is the underlying stimulus regulating systemic FMD. The mechanism underlying the hypoxia-induced elevation in retrograde SR in the peripheral artery remains to be established. However, a previous study reported that classic sympathetic stimuli, such as lower body negative pressure increased retrograde flow and SR along with increased muscle sympathetic nerve activity (MSNA), indicating that activation of the sympathetic nerve (i.e., MSNA) may increase the retrograde flow and SR in the BA [39]. Thus, the hypoxia-induced elevation in retrograde SR may be related to a hypoxia-induced elevation in MSNA [39, 40].

Cerebral FMD

In the present study, ICA blood flow increased at the 2nd h timepoint in hypoxia before returning to normoxic control values by the 4th h and thereonin (Fig. 2B). In contrast, no hypoxia-induced elevations were observed in BA flow (Fig. 2A) highlighting differential regulation across separate albeit functionally integrated vascular beds. While it was not our specific intent to focus on the precise mechanism(s) underlying this kinetic, it likely reflects some degree of initial ‘compensatory’ vasodilation to offset the reduction in arterial O2 content (CaO2) followed by (CaO2) ‘restoration’ facilitated by complex interactions between the respiratory and autonomic nervous systems, as indicated in our prior research highlighting progressive and antagonistic changes in the end-tidal partial pressure of oxygen (PETO2) and MAP [11].

In contrast to systemic FMD, hypoxia failed to alter cerebral FMD and this remained well preserved. Thus, the attenuated CDO2 in the anterior cerebral circulation observed in our prior study [11], cannot be attributed to changes in local EF. Importantly, a dissociation between the systemic (reduction) and cerebral (preservation) FMD response has also been documented in young smokers [33]. These findings indicate that the mechanism(s) underlying vascular EF are clearly site-specific. Indeed, it is well established that compared to the systemic vasculature, the cerebrovasculature is more CO2 sensitive to provide tighter coupling of O2 delivery via increased perfusion given its disproportionately high(er) bioenergetic demands to support resting synaptic transmission. Equally, the cerebrovasculature needs to protect the blood–brain barrier from over-perfusion when the limits of autoregulation are potentially compromized [41].

One potential mechanism underlying the regional (FMD) heterogeneity during hypoxia may be due to the fact that retrograde SR is not observed in the cerebral circulation [8, 23, 24, 28]. Indeed, systemic FMD was reduced in the face of elevated retrograde SR during hypoxia. Previous studies [8, 28] have demonstrated that anterograde SR dominates in the cerebral circulation, yet the underlying mechanisms remain to be established. It is possible that the different hemodynamic properties between the cerebral and systemic vasculature may reflect the contrasting flow profiles to which these anatomically distinct but functionally integrated vascular beds are exposed [41]. In contrast, cerebral (ICA) antegrade SR was lower relative to normoxia with no measurable impact on the (cerebral) FMD response. These findings suggest that (lack of change in) retrograde SR is the primary stimulus underlying vascular EF. This reduction in cerebral antegrade SR may simply be the consequence of hypoxia-induced vasodilation (Table 3, ICA Dbase, P < 0.001), an evolutionarily conserved response that strives to maintain CDO2 in the face of arterial hypoxemia, albeit inadequate in the present study.

Table 3 Cerebral flow-mediated dilation

Cerebral autoregulation can also modify the SR phenotype [42]. For example, continuous hypoxia decreases MAP [40, 43, 44] subsequent to hypoxia vasodilation and this can cause a reduction in cerebral antegrade SR subsequent to a decrease in blood flow velocity regardless of changes in blood flow. Another possible mechanism may be related to underlying differences between cerebral and systemic vasculature in the SR phenotype, the consequence of site-specific differences in anatomical/histological characteristics including redox status, hypoxia-induced sympathetic activation and the vascular territories they each subserve [23]. Since acute hypotension modifies systemic EF [31] hypoxia-induced hypotension may equally impact cerebral EF. The same concept applies for hypoxia-induced alterations in hemostasis and redox-status given their differential impact on systemic (and potentially cerebral) EF [15, 45, 46].

Hypoxia stimulation related flow/SR phenotype for cerebral EF

Recently, the elevation in ICA antegrade SR during cyclic intermittent hypoxia has been reported [7]; however, the underlying mechanism remains unclear. The authors suggested that a cyclic intermittent hypoxia-induced elevation in cardiac output increases anterograde SR without elevating sympathetic activity (arterial blood pressure). In contrast, continuous hypoxia increases sympathetic activation and arterial blood pressure [47]. Thus, we speculate that the differential hemodynamic responses may contribute to the observed differences in cerebral FMD. Indeed, cyclic intermittent hypoxia was shown to improve cerebral FMD subsequent to a flow-mediated elevation in antegrade SR [7], in stark contrast to what we observed in the present study employing a continuous exposure paradigm. These findings suggest that oscillatory stress imposed by the ‘intermittency’ of the stimulus (e.g., high-intensity interval exercise and/or hypoxia) is the key stimulus underling vascular endothelial adaptation [48]. A previous study [49] clearly demonstrated that oscillatory shear stress improves EF in the systemic vasculature but this occurs via increased in both retrograde and anterograde SR. Some previous studies [17, 27, 50, 51] reported that experimentally induced oscillatory shear stress causes a transient reduction in systemic FMD, and demonstrate that an increase in retrograde SR contributes to this oscillatory shear stress-induced endothelial dysfunction. Importantly, retrograde SR is absent in the cerebral vasculature [28]. In the cerebral circulation, hypoxia stimulates oscillatory SR more markedly relative to continuous hypoxia conditions due to the absence of retrograde SR which serves to reduce (total) SR and consequently, it may enhance cerebral EF. However, the brain appears more sensitive to structural perturbation/damage (e.g., increased blood–brain barrier permeability) compared to the systemic vasculature given its increased bioenergetic demands and limited aerobic/glycolytic energy reserves [52].

A previous review proposed that hypoxic conditioning may be harmless and represent a promising adjunct therapy for stroke patients [53]. However, in the present study, continuous hypoxia’failed’ to improve cerebral FMD (i.e., it was simply maintained). In contrast, cyclic intermittent hypoxia may prove a useful non-pharmacological adjunct therapy for patients with brain disease (i.e., after the onset of stroke) given its impact on cerebral FMD is ‘superior’.

Limitations

There are a number of limitations to the present study that warrant careful consideration. First, larger scale follow-up studies are encouraged to confirm our findings given the interpretive limitations associated with the relatively small sample sizes employed despite prospective adequate (prospective) powering of our study (albeit only against systemic FMD), including caveats associated with a Type M error [54]. While technical failure constrained our assessment of cerebral FMD to 5–6 participants, retrospective power calculations based on the observed effect size of 0.110 (calculated from partial η2 = 0.012), 1-β of 0.80, and α of 0.05, indicated that the sample size required to detect a treatment effect would be in excess of 200 participants, tentatively arguing against sample size inflation. Second, we chose to constrain our analyzes, focusing exclusively on men to (better) control for the potential vascular confounds caused by sex androgens [55]. There is an evolving body of literature suggesting that lifelong adaptation to hypoxia (phenotypical responses observed in native highlanders) confers neuroprotective benefits linked to more efficient redox-regulation of systemic [56, 57] and cerebrovascular [58] function and consequent O2 transport. It is conceivable that given such adaptations, highlanders may prove phenotypically less ‘responsive/sensitive’ to hypoxia although future studies are encouraged to better define the hypoxic dose stimulus (intensity/frequency/duration) and corresponding implications for integrated vascular endothelial function.

Conclusions

Our findings demonstrate that continuous steady-state exposure to hypoxia was associated with a reduction in systemic FMD, yet failed to impact cerebral FMD despite a reduction in ICA antegrade SR. These findings contrast with those observed during cyclic intermittent hypoxia [7], highlighting the regulatory importance of (hypoxia) dose duration and flow/SR phenotype. Understanding the latter is key to designing interventions to optimize integrated systemic and cerebrovascular function in patients suffering from circulatory disease and consequent hypoxemia.

Availability of data and materials

The data sets used and analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. Iwamoto E, Bock JM, Casey DP (2018) High-intensity exercise enhances conduit artery vascular function in older adults. Med Sci Sports Exerc 50(1):124–130

    Article  PubMed  PubMed Central  Google Scholar 

  2. Morishima T, Restaino RM, Walsh LK, Kanaley JA, Fadel PJ, Padilla J (2016) Prolonged sitting-induced leg endothelial dysfunction is prevented by fidgeting. Am J Physiol Heart Circ Physiol 311(1):H177–H182

    Article  PubMed  PubMed Central  Google Scholar 

  3. Tinken TM, Thijssen DH, Hopkins N, Black MA, Dawson EA, Minson CT et al (2009) Impact of shear rate modulation on vascular function in humans. Hypertension 54(2):278–285

    Article  CAS  PubMed  Google Scholar 

  4. Walther C, Gielen S, Hambrecht R (2004) The effect of exercise training on endothelial function in cardiovascular disease in humans. Exerc Sport Sci Rev 32(4):129–134

    Article  PubMed  Google Scholar 

  5. Pretnar-Oblak J, Zaletel M, Zvan B, Sabovic M, Pogacnik T (2006) Cerebrovascular reactivity to L-arginine in patients with lacunar infarctions. Cerebrovasc Dis 21(3):180–186

    Article  CAS  PubMed  Google Scholar 

  6. Toda N, Ayajiki K, Okamura T (2009) Cerebral blood flow regulation by nitric oxide: recent advances. Pharmacol Rev 61(1):62–97

    Article  CAS  PubMed  Google Scholar 

  7. Iwamoto E, Hanson BE, Bock JM (1985) Casey DP (2020) Intermittent hypoxia enhances shear-mediated dilation of the internal carotid artery in young adults. J Appl Physiol 129(3):603–611

    Article  CAS  Google Scholar 

  8. Ogoh S, Washio T, Suzuki K, Iemitsu M, Hashimoto T, Iwamoto E et al (2021) Greater increase in internal carotid artery shear rate during aerobic interval compared to continuous exercise in healthy adult men. Physiol Rep 9(2):e14705

    Article  PubMed  PubMed Central  Google Scholar 

  9. Mortimer EA Jr, Monson RR, MacMahon B (1977) Reduction in mortality from coronary heart disease in men residing at high altitude. N Engl J Med 296(11):581–585

    Article  PubMed  Google Scholar 

  10. Sharma S (1990) Clinical, biochemical, electrocardiographic and noninvasive hemodynamic assessment of cardiovascular status in natives at high to extreme altitudes (3000m–5500m) of the Himalayan region. Indian Heart J 42(5):375–379

    CAS  PubMed  Google Scholar 

  11. Ogoh S, Washio T, Stacey BS, Tsukamoto H, Iannetelli A, Owens TS et al (2021) Integrated respiratory chemoreflex-mediated regulation of cerebral blood flow in hypoxia: Implications for oxygen delivery and acute mountain sickness. Exp Physiol 106(9): 1922–1938

    Article  PubMed  Google Scholar 

  12. Bakker E, Engan H, Patrician A, Schagatay E, Karlsen T, Wisloff U et al (2015) Acute dietary nitrate supplementation improves arterial endothelial function at high altitude: a double-blinded randomized controlled cross over study. Nitric Oxide 50:58–64

    Article  CAS  PubMed  Google Scholar 

  13. Frick M, Rinner A, Mair J, Alber HF, Mittermayr M, Pachinger O et al (2006) Transient impairment of flow-mediated vasodilation in patients with metabolic syndrome at moderate altitude (1700 m). Int J Cardiol 109(1):82–87

    Article  PubMed  Google Scholar 

  14. Frobert O, Holmager P, Jensen KM, Schmidt EB, Simonsen U (2008) Effect of acute changes in oxygen tension on flow-mediated dilation Relation to cardivascular risk. Scand Cardiovasc J 42(1):38–47

    Article  PubMed  Google Scholar 

  15. Lewis NC, Bailey DM, Dumanoir GR, Messinger L, Lucas SJ, Cotter JD et al (2014) Conduit artery structure and function in lowlanders and native highlanders: relationships with oxidative stress and role of sympathoexcitation. J Physiol 592(5):1009–1024

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Lewis NCS, Bain AR, Wildfong KW, Green DJ, Ainslie PN (2017) Acute hypoxaemia and vascular function in healthy humans. Exp Physiol 102(12):1635–1646

    Article  CAS  PubMed  Google Scholar 

  17. Tremblay JC, Howe CA, Ainslie PN, Pyke KE (2018) UBC-Nepal Expedition: imposed oscillatory shear stress does not further attenuate flow-mediated dilation during acute and sustained hypoxia. Am J Physiol Heart Circ Physiol 315(1):H122–H131

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Tymko MM, Tremblay JC, Steinback CD, Moore JP, Hansen AB, Patrician A et al (1985) (2017) UBC-Nepal expedition: acute alterations in sympathetic nervous activity do not influence brachial artery endothelial function at sea level and high altitude. J Appl Physiol 123(5):1386–1396

    Article  Google Scholar 

  19. Iglesias D, Gomez Rosso L, Vainstein N, Merono T, Lezon C, Brites F (2015) Vascular reactivity and biomarkers of endothelial function in healthy subjects exposed to acute hypobaric hypoxia. Clin Biochem 48(16–17):1059–1063

    Article  CAS  PubMed  Google Scholar 

  20. Rieger MG, Hoiland RL, Tremblay JC, Stembridge M, Bain AR, Fluck D et al (2017) One session of remote ischemic preconditioning does not improve vascular function in acute normobaric and chronic hypobaric hypoxia. Exp Physiol 102(9):1143–1157

    Article  CAS  PubMed  Google Scholar 

  21. Tremblay JC, Thom SR, Yang M, Ainslie PN (2017) Oscillatory shear stress, flow-mediated dilatation, and circulating microparticles at sea level and high altitude. Atherosclerosis 256:115–122

    Article  CAS  PubMed  Google Scholar 

  22. Tymko MM, Tremblay JC, Hansen AB, Howe CA, Willie CK, Stembridge M et al (2017) The effect of alpha1—adrenergic blockade on post-exercise brachial artery flow-mediated dilatation at sea level and high altitude. J Physiol 595(5):1671–1686

    Article  CAS  PubMed  Google Scholar 

  23. Ogoh S (1985) Bailey DM (2021) Last Word on Viewpoint: Differential impact of shear rate in the cerebral and systemic circulation: implications for endothelial function. J Appl Physiol 130(4):1161–1162

    Article  Google Scholar 

  24. Ogoh S (1985) Bailey DM (2021) Differential impact of shear rate in the cerebral and systemic circulation: implications for endothelial function. J Appl Physiol 130(4):1152–1154

    Article  Google Scholar 

  25. Iwamoto E, Katayama K, Ishida K (2015) Exercise intensity modulates brachial artery retrograde blood flow and shear rate during leg cycling in hypoxia. Physiol Rep 3(6):e12423

    Article  PubMed  PubMed Central  Google Scholar 

  26. Tremblay JC, Hoiland RL, Carter HH, Howe CA, Stembridge M, Willie CK et al (2018) UBC-Nepal expedition: upper and lower limb conduit artery shear stress and flow-mediated dilation on ascent to 5050 m in lowlanders and Sherpa. Am J Physiol Heart Circ Physiol 315(6):H1532–H1543

    Article  CAS  PubMed  Google Scholar 

  27. Thijssen DH, Dawson EA, Tinken TM, Cable NT, Green DJ (2009) Retrograde flow and shear rate acutely impair endothelial function in humans. Hypertension 53(6):986–992

    Article  CAS  PubMed  Google Scholar 

  28. Rodrigues JCL, Strelko G, Warnert EAH, Burchell AE, Neumann S, Ratcliffe LEK et al (2020) Retrograde blood flow in the internal jugular veins of humans with hypertension may have implications for cerebral arterial blood flow. Eur Radiol 30(7):3890–3899

    Article  PubMed  Google Scholar 

  29. Woodside JD, Gutowski M, Fall L, James PE, McEneny J, Young IS et al (2014) Systemic oxidative-nitrosative-inflammatory stress during acute exercise in hypoxia; implications for microvascular oxygenation and aerobic capacity. Exp Physiol 99(12):1648–1662

    Article  CAS  PubMed  Google Scholar 

  30. Bailey DM, Davies B, Castell LM, Newsholme EA (1985) Calam J (2001) Physical exercise and normobaric hypoxia: independent modulators of peripheral cholecystokinin metabolism in man. J Appl Physiol 90(1):105–113

    Article  Google Scholar 

  31. Iwamoto E, Yamada Y, Katayose M, Sakamoto R, Neki T, Sugawara J et al (2020) Acute hypotension attenuates brachial flow-mediated dilation in young healthy men. Eur J Appl Physiol 120(1):161–169

    Article  PubMed  Google Scholar 

  32. Carter HH, Atkinson CL, Heinonen IH, Haynes A, Robey E, Smith KJ et al (2016) Evidence for shear stress-mediated dilation of the internal carotid artery in humans. Hypertension 68(5):1217–1224

    Article  CAS  PubMed  Google Scholar 

  33. Suzuki K, Washio T, Tsukamoto S, Kato K, Iwamoto E, Ogoh S (2020) Habitual cigarette smoking attenuates shear-mediated dilation in the brachial artery but not in the carotid artery in young adults. Physiol Rep 8(3):e14369

    Article  PubMed  PubMed Central  Google Scholar 

  34. Carr J, Hoiland RL, Caldwell HG, Coombs GB, Howe CA, Tremblay JC et al (2020) Internal carotid and brachial artery shear-dependent vasodilator function in young healthy humans. J Physiol 598(23):5333–5350

    Article  CAS  PubMed  Google Scholar 

  35. Woodman RJ, Playford DA, Watts GF, Cheetham C, Reed C, Taylor RR et al (1985) (2001) Improved analysis of brachial artery ultrasound using a novel edge-detection software system. J Appl Physiol 91(2):929–937

    Article  Google Scholar 

  36. Thijssen DHJ, Bruno RM, van Mil A, Holder SM, Faita F, Greyling A et al (2019) Expert consensus and evidence-based recommendations for the assessment of flow-mediated dilation in humans. Eur Heart J 40(30):2534–2547

    Article  PubMed  Google Scholar 

  37. Atkinson G, Batterham AM (2013) The percentage flow-mediated dilation index: a large-sample investigation of its appropriateness, potential for bias and causal nexus in vascular medicine. Vasc Med 18(6):354–365

    Article  PubMed  Google Scholar 

  38. Hopkins ND, Dengel DR, Stratton G, Kelly AS, Steinberger J, Zavala H et al (1985) (2015) Age and sex relationship with flow-mediated dilation in healthy children and adolescents. J Appl Physiol 119(8):926–933

    Article  Google Scholar 

  39. Padilla J, Young CN, Simmons GH, Deo SH, Newcomer SC, Sullivan JP et al (2010) Increased muscle sympathetic nerve activity acutely alters conduit artery shear rate patterns. Am J Physiol Heart Circ Physiol 298(4):H1128–H1135

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Rowell LB, Johnson DG, Chase PB, Comess KA (1985) Seals DR (1989) Hypoxemia raises muscle sympathetic activity but not norepinephrine in resting humans. J Appl Physiol 66(4):1736–1743

    Article  Google Scholar 

  41. Bailey DM, Rasmussen P, Overgaard M, Evans KA, Bohm AM, Seifert T et al (2017) Nitrite and S-nitrosohemoglobin exchange across the human cerebral and femoral circulation: relationship to basal and exercise blood flow responses to hypoxia. Circulation 135(2):166–176

    Article  CAS  PubMed  Google Scholar 

  42. Ainslie PN, Ogoh S (2010) Regulation of cerebral blood flow in mammals during chronic hypoxia: a matter of balance. Exp Physiol 95(2):251–262

    Article  PubMed  Google Scholar 

  43. Saito M, Mano T, Iwase S, Koga K, Abe H (1985) Yamazaki Y (1988) Responses in muscle sympathetic activity to acute hypoxia in humans. J Appl Physiol 65(4):1548–1552

    Article  Google Scholar 

  44. Tamisier R, Nieto L, Anand A, Cunnington D, Weiss JW (2004) Sustained muscle sympathetic activity after hypercapnic but not hypocapnic hypoxia in normal humans. Respir Physiol Neurobiol 141(2):145–155

    Article  PubMed  Google Scholar 

  45. Fall L, Brugniaux JV, Davis D, Marley CJ, Davies B, New KJ et al (2018) Redox-regulation of haemostasis in hypoxic exercising humans: a randomised double-blind placebo-controlled antioxidant study. J Physiol 596(20):4879–4891

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Fall L, New KJ, Evans KA, Bailey DM (2015) Arterial hypoxaemia and its impact on coagulation: significance of altered redox homeostasis. J Clin Pathol 68(9):752–754

    Article  CAS  PubMed  Google Scholar 

  47. Tamisier R, Anand A, Nieto LM, Cunnington D (1985) Weiss JW (2005) Arterial pressure and muscle sympathetic nerve activity are increased after two hours of sustained but not cyclic hypoxia in healthy humans. J Appl Physiol 98(1):343–349

    Article  Google Scholar 

  48. Calverley TA, Ogoh S, Marley CJ, Steggall M, Marchi N, Brassard P et al (2020) HIITing the brain with exercise: mechanisms, consequences and practical recommendations. J Physiol 598(13):2513–2530

    Article  CAS  PubMed  Google Scholar 

  49. Holder SM, Dawson EA, Brislane A, Hisdal J, Green DJ (1985) Thijssen DHJ (2019) Fluctuation in shear rate, with unaltered mean shear rate, improves brachial artery flow-mediated dilation in healthy, young men. J Appl Physiol 126(6):1687–1693

    Article  Google Scholar 

  50. Schreuder TH, Green DJ, Hopman MT, Thijssen DH (2014) Acute impact of retrograde shear rate on brachial and superficial femoral artery flow-mediated dilation in humans. Physiol Rep 2(1):e00193

    Article  PubMed  PubMed Central  Google Scholar 

  51. Thijssen DH, Schreuder TH, Newcomer SW, Laughlin MH, Hopman MT, Green DJ (2015) Impact of 2-Weeks continuous increase in retrograde shear stress on brachial artery vasomotor function in young and older men. J Am Heart Assoc 4(10):e001968

    Article  PubMed  PubMed Central  Google Scholar 

  52. Bailey DM (2019) Oxygen and brain death; back from the brink. Exp Physiol 104(12):1769–1779

    Article  CAS  PubMed  Google Scholar 

  53. Verges S, Chacaroun S, Godin-Ribuot D, Baillieul S (2015) Hypoxic conditioning as a new therapeutic modality. Front Pediatr 3:58

    Article  PubMed  PubMed Central  Google Scholar 

  54. Gelman A, Carlin J (2014) Beyond power calculations: assessing type S (Sign) and type M (magnitude) errors. Perspect Psychol Sci 9(6):641–651

    Article  PubMed  Google Scholar 

  55. Krejza J, Rudzinski W, Arkuszewski M, Onuoha O, Melhem ER (2013) Cerebrovascular reactivity across the menstrual cycle in young healthy women. Neuroradiol J 26(4):413–419

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Bailey DM, Culcasi M, Filipponi T, Brugniaux JV, Stacey BS, Marley CJ et al (2022) EPR spectroscopic evidence of iron-catalysed free radical formation in chronic mountain sickness: dietary causes and vascular consequences. Free Radic Biol Med 184:99–113

    Article  CAS  PubMed  Google Scholar 

  57. Bailey DM, Rimoldi SF, Rexhaj E, Pratali L, Salinas Salmon C, Villena M et al (2013) Oxidative-nitrosative stress and systemic vascular function in highlanders with and without exaggerated hypoxemia. Chest 143(2):444–451

    Article  CAS  PubMed  Google Scholar 

  58. Bailey DM, Brugniaux JV, Filipponi T, Marley CJ, Stacey B, Soria R et al (2019) Exaggerated systemic oxidative-inflammatory-nitrosative stress in chronic mountain sickness is associated with cognitive decline and depression. J Physiol 597(2):611–629

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We appreciate the commitment of all participants.

Funding

S.O. is supported by a Grant-in-Aid for Scientific Research [Grant Number 18H03156] from the Japanese Ministry of Education, Culture, Sports, Science and Technology. DMB was supported by a Royal Society Wolfson Research Fellowship (#WM170007), Japan Society for the Promotion of Science (#JSPS/OF317) and Higher Education Funding Council for Wales (postdoctoral fellowships for BSS and AI).

Author information

Authors and Affiliations

Authors

Contributions

SO, BSS and DMB. designed the research; SO, TW, BSS, HT, AI, TSO, TAC, LF, CJM and DMB performed experiments and data acquisition; SO, TW, BSS and DMB analyzed data; SO, TW, BSS and DMB interpreted results of experiments; TW prepared figures; SO and DMB drafted manuscript; all authors edited and revised manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Damian M. Bailey.

Ethics declarations

Ethics approval and consent to participate

The study was approved by the Ethics Committee of the University of South Wales, UK (#201712BS01). All procedures were carried out in accordance with the most (7th) recent amendment of the Declaration of Helsinki of the World Medical Association (with the exception that it was not registered in a publicly accessible database prior to recruitment) with verbal and written informed consent obtained from all participants.

Consent for publication

Not applicable.

Competing interests

D.M.B. is a member of the Southeast Wales Vascular Network, National Cardiovascular Research Network and MRC Traumatic Brain Injury Committee; Chair of the Life Sciences Working Group and member of the Human Spaceflight and Exploration Science Advisory Committee to the European Space Agency and Space Exploration Advisory Committee to the UK Space Agency. He has interacted with members of the company FloTBI Inc. and Terumo UK focusing on the technological development and clinical application of novel biomarkers of brain injury in humans.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ogoh, S., Washio, T., Stacey, B.S. et al. Effects of continuous hypoxia on flow-mediated dilation in the cerebral and systemic circulation: on the regulatory significance of shear rate phenotype. J Physiol Sci 72, 16 (2022). https://doi.org/10.1186/s12576-022-00841-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12576-022-00841-5

Keywords

  • Hypoxia
  • Cerebral blood flow
  • Flow-mediated dilation
  • Endothelial function
  • Antegrade shear rate
  • Retrograde shear rate